Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

Severe RSV can lead to serious outcomes. Elderly or immunocompromised patients in Singapore face an increased risk of cardiovascular complications such as heart failure and secondary pneumonia.

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

Reformulated flu and COVID-19 shots are available to Oregonians starting this month. And an RSV vaccine — developed only last ...

ADMA stock surges 76.2% in three months on strong performance and high growth prospects. It recently hit its 52-week high ...

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...

Brits are being urged to book their winter vaccines for the flu, covid-19 and RSV ahead of time - as public health bosses say ...

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

All flu vaccines for the 2024-25 season will be trivalent, meaning they protect against three different strains of influenza: ...

NHS bosses are encouraging those eligible to 'protect themselves and people around them' by making an appointment for their ...

New York hospitals are treating an increased number of alternative-level of care patients, another example of bed shortages ...

GP practices should be working with complex patients to ‘actively avoid hospital admissions’ this winter, according to NHS ...